The US government is buying radioactive drugs from a single supplier in Texas
What happened
The US government awarded a contract worth over $650,000 for radiopharmaceuticals. This means a single company in Texas will supply these specialized radioactive drugs.
Why it matters
Radiopharmaceuticals are used for medical imaging and cancer treatment. They have a short shelf life and require specialized handling, making their supply chain fragile. Relying on a single supplier for these critical drugs could create vulnerabilities if that supplier faces disruptions.
The signal
Watch for future procurement notices to see if the government diversifies its suppliers for radiopharmaceuticals or continues to rely on a single source.